Enzo Biochem Inc (ENZ) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Enzo Biochem Inc

NYSE | ENZ

0.31

USD

-0.0678 (-17.77%)

AT CLOSE (AS OF Apr 17, 2025)

$16M

MARKET CAP

P/E Ratio

-0.14

EPS

$1.2

52 Week High

$0.25

52 Week Low

LIFE SCIENCES

Sector

ENZ Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

ENZ Technicals

Tags:

ENZ Earnings

Yearly Income Statement (As of Jul 31, 2024)

Field	Value (USD)
Gross Profit	$15M
Total Revenue	$32M
Cost Of Revenue	$17M
Costof Goods And Services Sold	$17M
Operating Income	-$9.8M
Selling General And Administrative	$24M
Research And Development	$2.6M
Operating Expenses	$27M
Investment Income Net	-
Net Interest Income	$3.3M
Interest Income	$3.5M
Interest Expense	$197K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$1.3M
Income Before Tax	-$9.8M
Income Tax Expense	$16M
Interest And Debt Expense	-
Net Income From Continuing Operations	-$9.8M
Comprehensive Income Net Of Tax	-
Ebit	-$9.6M
Ebitda	-$8.3M
Net Income	-$26M

Revenue & Profitability

Earnings Performance

ENZ Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Jul 31, 2024)

Field	Value (USD)
Total Assets	$86M
Total Current Assets	$70M
Cash And Cash Equivalents At Carrying Value	$52M
Cash And Short Term Investments	$52M
Inventory	$6.8M
Current Net Receivables	-
Total Non Current Assets	$16M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$6.8M
Other Non Current Assets	-
Total Liabilities	$30M
Total Current Liabilities	$25M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$917K
Total Non Current Liabilities	$4.9M
Capital Lease Obligations	$3.2M
Long Term Debt	$189K
Current Long Term Debt	$76K
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$3.5M
Other Current Liabilities	$23M
Other Non Current Liabilities	-
Total Shareholder Equity	$56M
Treasury Stock	-
Retained Earnings	-$294M
Common Stock	$521K
Common Stock Shares Outstanding	$51M

yearly Cash Flow (As of Jul 31, 2024)

Field	Value (USD)
Operating Cashflow	-$26M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$1.3M
Capital Expenditures	$545K
Change In Receivables	-
Change In Inventory	$1.1M
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$4.2M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$26M

yearly Income Statement (As of Jul 31, 2024)

Field	Value (USD)
Gross Profit	$15M
Total Revenue	$32M
Cost Of Revenue	$17M
Costof Goods And Services Sold	$17M
Operating Income	-$9.8M
Selling General And Administrative	$24M
Research And Development	$2.6M
Operating Expenses	$27M
Investment Income Net	-
Net Interest Income	$3.3M
Interest Income	$3.5M
Interest Expense	$197K
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$1.3M
Income Before Tax	-$9.8M
Income Tax Expense	$16M
Interest And Debt Expense	-
Net Income From Continuing Operations	-$9.8M
Comprehensive Income Net Of Tax	-
Ebit	-$9.6M
Ebitda	-$8.3M
Net Income	-$26M

Dividends

Field	Value
Ex Dividend Date	2024-11-15
Declaration Date	2024-10-29
Record Date	2024-11-15
Payment Date	2024-12-02
Amount	0.1

ENZ Profile

Enzo Biochem Inc Profile

Sector: LIFE SCIENCES

Industry: SERVICES-MEDICAL LABORATORIES

Enzo Biochem, Inc., an integrated diagnostic, clinical laboratory, and life science company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company is headquartered in New York, New York.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.00	9.68%	-	409,386,220
STSS	$0.03	20.75%	$522.68K	391,799,240
NVDA	$101.49	-2.87%	$2.48T	292,517,465
HTZ	$8.24	44.31%	$2.54B	266,908,117
FMTO	$0.02	-35.81%	$2.41M	198,396,141

Symbol	Price	Change %	Market Cap	Volume
LLY	$839.96	14.30%	$754.27B	10,853,385
PG	$170.63	2.55%	$400.10B	7,227,061
JNJ	$157.47	2.31%	$379.48B	10,981,067
ABBV	$172.99	0.76%	$306.02B	8,998,056
NVO	$58.08	-7.63%	$282.79B	32,220,629

Symbol	Price	Change %	Market Cap	Volume
MSGM	$2.75	145.54%	$8.75M	36,058,545
SXTC	$2.16	118.42%	$29.73M	51,508,885
ADGM	$1.78	92.81%	$54.65M	114,733,769
PNBK	$3.28	73.55%	$13.04M	1,511,087
RTC	$0.37	72.09%	$10.86M	187,018,434

Symbol	Price	Change %	Market Cap	Volume
JEWL	$0.00	-90.83%	$2.78M	470,134
LXEH	$6.84	-70.25%	$26.82M	1,373,607
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644

Quick Links

ENZ $0.31 (-17.77%) Quote details